/b/veterinary-news/posts/dechra-expands-in-europe-with-163-61-million-aquisition Dechra Pharmaceuticals PLC has announced that it has conditionally agreed to acquire VetXX for £61.7 million on a cash free, debt free basis, payable in cash upon completion. VetXX is a leading developer, producer and marketer of companion animalen-USTelligent Community 10